Detection of Mycobacterium leprae in nasal mucosa biopsies by the polymerase chain reaction.
Several discoveries about leprosy indicate that Mycobacterium leprae transmission mainly occurs by inhalation, and the nose is major port of entry and exit. The present study evaluated the clinical application of PCR for detection of M. leprae DNA in nasal mucosa biopsies in untreated leprosy patients (52) and their contacts (99) from the State Reference Center in Sanitary Dermatology and Leprosy, Uberlandia, MG, Brazil. PCR detection of a 372-base pair DNA fragment from M. leprae was accomplished in 36 (69.2%) patients, from which 34 (91.9%) of them were multibacillaries. Furthermore, PCR was positive in 3 (16.7%) of 18 slit-skin smear negative, 4 (25.0%) of 16 skin lesion BI negative, 8 (33.3%) of 24 nasal mucosa BI negative patients, and 10 of 99 contacts (10.1%). The presence of bacilli in 10.1% of the contacts may potentially reflect an occult leprosy, and these patients must be accompanied, followed by a chemoprophylaxy treatment. Considering all PCR results against clinical and BI classification of patients and controls, we have found a sensitivity of 69.2%, a specificity of 89.9%, and an accuracy of 82.8%. It has been demonstrated here through PCR of nasal biopsies that the bacillus invades the mucosa, passing through the nasal inferior turbinate to reach peripheral blood. Therefore, the molecular investigation of invasive nasal biopsies by PCR tests has proven to be useful in defining patients of higher risk of transmission and risk-group contacts, which is an important step to reach the World Health Organization objective towards the elimination of leprosy as a public health problem.
Patrocínio
Lucas Gomes
LG
State Reference Center for Sanitary Dermatology and Leprosy, Clinical Hospital, Faculty of Medicine, Federal University of Uberlândia, Minas Gerais, Brazil.
Goulart
Isabela Maria Bernardes
IM
Goulart
Luiz Ricardo
LR
Patrocínio
José Antônio
JA
Ferreira
Frederico Rogério
FR
Fleury
Raul Negrão
RN
D001706:Biopsy; D001938:Brazil / Q000453:epidemiology; D004269:DNA, Bacterial / Q000032:analysis; D006801:Humans; D007918:Leprosy / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology; D009166:Mycobacterium leprae / Q000235:genetics / Q000302:isolation & purification*; D009297:Nasal Mucosa / Q000382:microbiology* / Q000473:pathology; D016133:Polymerase Chain Reaction; D012307:Risk Factors; D012680:Sensitivity and Specificity
D004269:DNA, Bacterial